Labelling of ceftriaxone with 99mTc and its bio-evaluation as an infection imaging agent

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 57, Issue 11, 2014, Pages 652-657

  Sohaib, Muhammad ^a   Khurshid, Zain ^b   Roohi, Samina ^c  

^a PAKISTAN INSTITUTE OF ENGINEERING AND APPLIED SCIENCES   (Pakistan)

^b PAKISTAN ATOMIC ENERGY COMMISSION   (Pakistan)

^c PAKISTAN INSTITUTE OF NUCLEAR SCIENCE AND TECHNOLOGY   (Pakistan)

Author keywords

99mTc ceftriaxone infection imaging; Radiolabelled antibiotic; Third generation cephalosporin

Indexed keywords

ANIMALS; CHLORINE COMPOUNDS; ESCHERICHIA COLI; NUCLEAR MEDICINE; PATHOLOGY;

99MTC-CEFTRIAXONE INFECTION IMAGING; ANIMAL MODEL; BIODISTRIBUTIONS; CEFTRIAXONE; E. COLI; IN-VITRO; LABELINGS; RADIOLABELED ANTIBIOTIC; THIRD GENERATION; THIRD-GENERATION CEPHALOSPORIN;

ANTIBIOTICS;

CEFTRIAXONE; TECHNETIUM 99M; TURPENTINE OIL; RADIOPHARMACEUTICAL AGENT; TECHNETIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; DRUG BINDING; DRUG DISTRIBUTION; DRUG SCREENING; DRUG STABILITY; DRUG STRUCTURE; ESCHERICHIA COLI; IN VITRO STUDY; INFLAMMATION; NONHUMAN; PH MEASUREMENT; RAT; SCINTIGRAPHY; STAPHYLOCOCCUS AUREUS; STOICHIOMETRY; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; DRUG EFFECTS; MALE; RABBIT; SCINTISCANNING; SPRAGUE DAWLEY RAT; STAPHYLOCOCCUS INFECTION; SYNTHESIS; TISSUE DISTRIBUTION;

ANIMALS; CEFTRIAXONE; ESCHERICHIA COLI; MALE; RABBITS; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TECHNETIUM; TISSUE DISTRIBUTION;

EID: 84915794788     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.3235     Document Type: Article

References (18)

1. O. C. Boerman, C. P. Bleeker-Rovers, H. J. Rennen, W. J. G. Oyen, F. H. Corstens, in Clinical Nuclear Medicine, (Eds: G.J.R. Cook, M.N. Maisey, K. E. Britton, V. Chengazi), Hodder Arnold, London, 2006, pp. 93-106
2. J. W. Froelich, D. Swanson, Semin. Nucl. Med. 1984, 14, 128
3. C. P. Bleeker-Rovers, F. J. Vos, F. H. M. Corstens, in Clinical Nuclear Medicine, (Eds: H. J. Biersack, L. M. Freeman), Springer-Verlag, Berlin, 2007, pp. 347-359
4. K. K. Solanki, J. Bomanji, Q. Siraj, M. Small, K. E. Britton, J. Nucl. Med. 1993, 34(suppl),119
5. S. Vinjamuri, K. K. Solanki, J. Bomanji, Q. Siraj, K. E. Britton, A. V. Hall, E. O'Shaughnessy, S. S. Das, Lancet. 1996, 347, 233.
6. S. Sonmezoglu, M. Sonmezoglu, M. Halac, I. Akgü, C. Türkmen, C. Önsel, B. Kanmaz, K. Solanki, K. E. Britton, I. Uslu, J. Nucl. Med. 2001, 42, 567.
7. K. E. Britton, D. W. Wareham, S. S. Das, K. K. Solanki, H. Amaral, A. Bhatnagar, A. H. S. Katamihardja, J. Malamitsi, H. M. Moustafa, V. E. Soroa, F. X. Sundram, A.K. Padhy, J. Clin. Pathol. 2002, 55, 817
8. L. Sarda, A.C. Crémieux, Y. Lebellec, A. Meulemans, R. Lebtahi, G. Hayem, R. Génin, N. Delahaye, D. Huten, D.L. Guludec, J. Nucl. Med. 2003, 44, 920
9. R. H. Siaens, H. J. Rennen, O. C. Boerman, R. Dierckx, G. Slegers, J. Nucl. Med. 2004, 45, 2088.
10. N. Dumarey, D. Blocklet, T. Appelboom, L. Tant, A. Schoutens, Eur. J. Nucl. Med. 2002, 29, 530
11. A. Benitez, M. Roca, J. Martin-Comin, Q. J. Nucl. Med. Mol. Im. 2006, 50,147.
12. B. V. Gomes, G. Rabiller, F. Iglesias, V. Soroa, F. Tubau, M. Roca, J. C. Martín, Rev. Esp. Med. Nucl. 2005, 24, 312
13. D. Özdemir, M. Asikoglu, H. Ozkilic, F. Yilmaz, M. H. Limoncu, S. Ayhand, J. Label Compd. Radiopharm, 2014, 57, 36
14. L. McDowell, B. N. Kim, D. L. Paterson, in Kucers': The Use of Antibiotics, (Ed: M.L. Grayson), Edward Arnold, London, 2010, pp. 351-389.
15. M. M. Welling, A. A. Paulusma, H. S. Balter, E. K. J. Pauwels, P. H. Nibbering, Eur. J. Nucl. Med. 2000, 27, 292.
16. G. B. Saha, Fundamentals of Nuclear Pharmacy, Springer, New York, 2010.
17. A. Fazli, M. Salouti, M. Mazidi, J. Radioanal. Nucl. Chem. 2013, 298, 1227
18. M. Mostafa, M. A. Motaleb, T. M. Sakr, Appl. Radiat. Isotopes. 2010, 68, 1959